The clinical trials on this list are for non-small cell lung cancer. All trials on the list are NCI-supported clinical trials, which are sponsored or otherwise financially supported by NCI. NCI’s …

This phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or prostate cancer that has …

This phase II trial studies how well osimertinib, surgery, and radiation therapy work in treating patients with stage IIIB or IV non-small cell lung cancer with EGFR mutations.

The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) tumor samplesand to investigate …

This phase I/Ib trial studies the side effects and best dose of CB-839 HCl when given together with sapanisertib in treating patients with non-small cell lung cancer that has spread to other …

A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer This study aims to see how well a new drug, …

Lung cancer is the leading cause of cancer deaths globally. Non-small cell lung cancer, which originates from larger cells such as the epithelial cells lining the airways or mucus-producing …

This clinical trial studies combination chemotherapy, radiation therapy, and bevacizumab in treating patients with newly diagnosed stage III non-small cell lung cancer that cannot be …

Non-Small Cell Lung Cancer Developing New Therapies for Non-Small Cell Lung Cancer Over the last 10 years the Non-Small Cell Lung Cancer (NSCLC) clinical research market has …

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of …